Akari Therapeutics Plc Quarterly Accrued Liabilities, Current in USD from Q4 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Akari Therapeutics Plc quarterly Accrued Liabilities, Current history and growth rate from Q4 2011 to Q3 2024.
  • Akari Therapeutics Plc Accrued Liabilities, Current for the quarter ending September 30, 2024 was $2.61M.
Accrued Liabilities, Current, Quarterly (USD)
Accrued Liabilities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $2.61M Sep 30, 2024 10-Q 2024-11-19
Q2 2024 $4.4M +$2M +83.3% Jun 30, 2024 8-K 2024-09-06
Q1 2024 $1.53M Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $1.57M -$472K -23.2% Dec 31, 2023 10-Q 2024-11-19
Q2 2023 $2.4M +$991K +70.3% Jun 30, 2023 6-K 2023-09-29
Q4 2022 $2.04M -$1.15M -36% Dec 31, 2022 8-K 2024-09-06
Q2 2022 $1.41M -$146K -9.38% Jun 30, 2022 6-K 2022-09-27
Q4 2021 $3.18M +$1.35M +73.1% Dec 31, 2021 20-F 2023-05-01
Q2 2021 $1.56M -$385K -19.8% Jun 30, 2021 6-K 2021-09-22
Q4 2020 $1.84M -$2.39M -56.5% Dec 31, 2020 20-F 2022-05-16
Q3 2020 $976K -$2.06M -67.8% Sep 30, 2020 20-F 2021-04-21
Q2 2020 $1.94M -$730K -27.3% Jun 30, 2020 20-F 2021-04-21
Q1 2020 $2.63M +$1.01M +61.9% Mar 31, 2020 20-F 2021-04-21
Q4 2019 $4.23M +$2.74M +184% Dec 31, 2019 20-F 2021-04-21
Q3 2019 $3.04M Sep 30, 2019 20-F 2021-04-21
Q2 2019 $2.67M -$1.32M -33% Jun 30, 2019 20-F 2021-04-21
Q1 2019 $1.63M Mar 31, 2019 20-F 2021-04-21
Q4 2018 $1.49M -$3.31M -68.9% Dec 31, 2018 20-F 2020-03-31
Q2 2018 $3.99M +$2.68M +206% Jun 30, 2018 6-K 2018-09-27
Q4 2017 $4.8M +$2.96M +161% Dec 31, 2017 20-F 2019-04-23
Q2 2017 $1.31M +$945K +262% Jun 30, 2017 6-K 2017-08-10
Q4 2016 $1.84M +$1.43M +350% Dec 31, 2016 20-F 2018-07-18
Q2 2016 $361K Jun 30, 2016 6-K/A 2017-04-14
Q1 2016 $232K Mar 31, 2016 10-Q 2016-05-12
Q4 2015 $408K +$365K +849% Dec 31, 2015 6-K/A 2017-04-14
Q3 2015 $3.85M Sep 30, 2015 10-Q 2015-11-23
Q4 2014 $43K -$360K -89.3% Dec 31, 2014 10-K 2016-03-23
Q4 2013 $403K -$493K -55% Dec 31, 2013 10-K 2015-02-11
Q4 2012 $896K +$298K +49.8% Dec 31, 2012 20-F 2014-03-24
Q4 2011 $598K Dec 31, 2011 20-F/A 2013-04-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.